Meibomian Gland Dysfunction (MGD)
Understanding Meibomian Gland Dysfunction
Meibomian gland dysfunction, commonly known as MGD, is one of the most frequent causes of dry eye symptoms and affects millions of people. The meibomian glands are tiny oil-producing glands that line the edges of your upper and lower eyelids and produce an essential oil layer that prevents your tears from evaporating too quickly. When these glands become blocked or stop functioning properly, the result is often persistent eye discomfort that can worsen over time without treatment. According to a study published in The Ocular Surface, an estimated 70% of the US population over age 60 has meibomian gland dysfunction, highlighting the strong relationship between aging and gland deterioration (The Ocular Surface, 2023).
Your eyelids contain approximately 25 to 40 meibomian glands in the upper lid and 20 to 30 in the lower lid. These tiny, sebaceous glands run vertically through the eyelid tissue and open along the lid margin just behind the lash line. Each time you blink, the glands release a thin layer of oil called meibum that spreads across the surface of your tears to slow evaporation.
Your tear film consists of three layers: a mucin layer that helps tears adhere to the eye, a watery aqueous layer that provides moisture, and an outer lipid layer produced by the meibomian glands. When MGD reduces the quantity or quality of the lipid layer, your tears evaporate faster than they should. This leads to a condition known as evaporative dry eye, which accounts for the majority of dry eye cases. Over time, this cycle of rapid evaporation and inadequate lubrication can cause chronic irritation and damage to the surface of the eye.
MGD is broadly categorized based on whether it involves reduced secretion or altered composition of the meibum. Obstructive MGD is the most common form and occurs when thickened meibum or keratinized tissue blocks the gland openings. Hyposecretory MGD, which is less common, involves glands that produce too little oil even without a visible obstruction. In some cases, both mechanisms contribute to gland dysfunction simultaneously.
Causes of Meibomian Gland Dysfunction
A number of factors can contribute to the development of MGD, and many patients have more than one contributing cause. MGD becomes increasingly common with age, particularly after age 50, as gland function naturally declines over time. Hormonal changes also play a significant role. Decreased androgen levels, which can occur during menopause or as a result of certain medications, reduce meibomian gland activity and change the composition of meibum. This is one reason why MGD and dry eye symptoms are more prevalent in women, especially during and after menopause.
Prolonged screen use reduces your blink rate, which limits the natural expression of meibum from the glands. Low-humidity environments, air conditioning, and forced-air heating can accelerate tear evaporation and compound the effects of reduced oil production. Contact lens wear has also been linked to meibomian gland changes, including gland shortening and dropout over time. Patients who spend many hours on digital devices each day while also wearing contact lenses may be at particularly elevated risk for developing MGD-related symptoms.
Several classes of medication can impair meibomian gland function. Isotretinoin, commonly prescribed for acne, is one of the most well-known causes because it shrinks sebaceous glands throughout the body, including the meibomian glands. Antihistamines, antidepressants, hormone replacement therapy containing estrogen, and certain glaucoma eye drops have also been associated with reduced meibomian gland output.
Blepharitis, a chronic inflammation of the eyelid margin, frequently coexists with MGD and can worsen gland blockages. Rosacea, a skin condition that causes facial redness and inflammation, is another common contributor. Autoimmune conditions such as Sjogren syndrome and allergic eye disease may also affect meibomian gland health. Demodex mites, tiny organisms that can inhabit the eyelash follicles, have been linked to both blepharitis and MGD in many patients.
Symptoms of MGD
The symptoms of MGD often overlap with general dry eye, which is why a thorough evaluation is essential to identify the underlying cause. Many patients with MGD experience a gritty or sandy sensation in the eyes, as though something is irritating the surface. Other frequent dry eye symptoms include burning, stinging, redness along the lid margins, and intermittent blurry vision that temporarily clears with blinking. Some patients notice their eyes feel worse in the morning due to incomplete lid closure during sleep, while others find symptoms intensify throughout the day, especially after extended reading or screen use.
In the early stages, MGD may cause only mild or occasional discomfort that is easy to dismiss. As the glands become more chronically obstructed, the oil they produce thickens and becomes increasingly difficult to express. Over months to years, blocked glands can atrophy and lose their ability to function entirely. This is why early detection and treatment are important for preserving gland structure before permanent changes occur.
Because MGD can produce redness, tearing, and irritation, it is sometimes confused with conjunctivitis or other forms of dry eye. Allergic eye disease, contact lens discomfort, and blepharitis can all mimic or coexist with MGD. Our dry eye specialists use targeted diagnostic tools to distinguish between these conditions and develop an accurate, individualized treatment plan.
How MGD Is Diagnosed
Diagnosing MGD requires more than a standard eye exam. Our dry eye specialists use a combination of clinical evaluation and advanced imaging to assess gland health. During your evaluation, your doctor will carefully examine the eyelid margins for signs of inflammation, thickening, or irregular gland openings. Gentle pressure is applied to the eyelids to express the meibum and assess its quality. Healthy meibum should be clear and flow freely, while dysfunctional glands often produce thick, cloudy, or toothpaste-like secretions that indicate obstruction.
Meibography is a non-invasive imaging technique that uses infrared light to photograph the meibomian glands through the eyelid. The resulting images reveal the size, shape, and structural integrity of each gland, allowing your doctor to identify areas of gland dropout, shortening, or atrophy. At Greenwich Ophthalmology Associates, we use LipiView imaging to capture these meibography scans, providing a clear baseline measurement that can be used to monitor changes over time and guide treatment decisions.
Additional tests may include tear break-up time, which measures how quickly your tear film becomes unstable after a blink, and tear osmolarity testing, which evaluates the salt concentration in your tears. Fluorescein staining can reveal areas of the cornea or conjunctiva that have been damaged by insufficient lubrication. Together, these findings help determine the severity of your MGD and shape a targeted treatment approach.
Frequently Asked Questions
Meibography uses infrared imaging to capture detailed pictures of your meibomian glands without touching the eye. Your doctor gently everts the eyelid and takes the image in seconds. The scan reveals whether glands have shortened, thinned, or dropped out entirely, giving a clear picture of how much functional gland tissue remains.
Treatment for MGD depends on its severity and is typically approached in a stepwise fashion. Mild cases may respond well to consistent warm compresses and lid hygiene performed at home. Moderate to severe cases often benefit from in-office procedures such as thermal pulsation therapy, intense pulsed light treatment, or meibomian gland expression performed by your doctor. Prescription anti-inflammatory drops or oral medications may also be recommended to address underlying inflammation.
LipiFlow is a thermal pulsation device that applies controlled heat to the inner surface of the eyelid while simultaneously delivering gentle, pulsed pressure to the outer lid. This combination softens hardened meibum and clears gland blockages during a single 12-minute session. Clinical studies have shown that LipiFlow can significantly improve meibomian gland secretion and tear film stability, with benefits lasting up to nine months or longer in many patients.
Warm compresses are one of the most accessible and effective home treatments for MGD. Applying consistent, sustained heat to the closed eyelids for 10 to 15 minutes helps soften thickened meibum so it can flow more freely from the glands. For best results, use a microwavable eye mask designed to maintain steady warmth, and follow each session with gentle lid massage to help express the softened oils.
MGD is generally considered a chronic condition that can be effectively managed but not fully cured. With consistent treatment, most patients experience significant symptom relief and improved gland function. However, meibomian glands that have already atrophied cannot regenerate, which is why early intervention matters. Ongoing maintenance helps preserve remaining gland function and keep symptoms under control.
MGD is the leading cause of evaporative dry eye, which is the most common form of dry eye disease. When the meibomian glands fail to produce adequate oil, tears evaporate too quickly, leaving the eye surface exposed and vulnerable to irritation. Treating the gland dysfunction directly often produces more lasting relief than artificial tears alone, because it addresses the root cause of tear film instability.
What our Patients say
4.8
Reviews
(3,408)